WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1'5501 Infant (under 12 months) mortality rate: 672
GDP / capita (US$): 3'4841 Child (under 5 years) mortality rate: 932

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 22'702  22'157  21'622  21'103  20'604  16'518  12'166  8'266 
Births 838  824  809  794  779  671  524  399 
Surviving infants 781  766  750  735  719  607  469  352 
Pop. less than 5 years 3'667  3'586  3'504  3'426  3'356  2'846  2'157  1'599 
Pop. less than 15 years 9'642  9'467  9'292  9'120  8'951  7'177  5'442  3'757 
Female 15-49 years 5'314  5'155  4'998  4'846  4'702  3'660  2'560  1'703 

Number of reported cases

(Click for retrospective incidence data for Côte d'Ivoire)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  65  50  48  137  628  5'729  17'799  7'633 
Mumps
ChartChart
 
Pertussis
ChartChart
  3'052 
Polio*
ChartChart
  36  28  47 
Rubella
ChartChart
  50  54  98  298  43 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  12  15  30  364 
Tetanus (total)**
ChartChart
  12  15  384 
Yellow fever
ChartChart
  15  21  10 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Côte d'Ivoire)
Vaccine year result method % card seen                                                
BCG 2014  87  CES   91  79  84  90  99  74  76 
DTP1 2014  91  CES   91  99*  93  99*  75  83 
DTP3 2014  76  CES   91  91  87  99*  94  62  62 
DTP4         
IPV1          39 
HepB_BD         
HepB3 2014  76  CES   91  91  87  99*  94  62 
Hib3 2014  76  CES   91  91  87  99*  94  62 
JapEnc         
MCV1          82  72  85  85  49  62 
MCV2         
PCV1          99*  15 
PCV3          81 
Pol3 2014  76  CES   91  88  85  98  94  58  61  56 
Rota1         
RotaC         
Rubella1         
TT2plus 2015  86  CES   91  80  77  81  84  59  78 
PAB         
VAD1          75  99*  99* 
YFV 2014  49  CES   91  58  58  84  81  49  55 
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Côte d'Ivoire)
BCG
ChartChart
  79  84  90  93  74  80  62 
DTP1
ChartChart
  99  93  89  93  75  85  77 
DTP3
ChartChart
  83  76  80  82  62  65  54 
HepB3
ChartChart
  83  76  80  82  62 
HepB_BD
ChartChart
 
Hib3
ChartChart
  83  76  80  82  62 
IPV1
ChartChart
  39 
MCV1
ChartChart
  72  62  76  74  49  68  56 
MCV2
ChartChart
 
PAB
ChartChart
  85  82  82  82  82  76  36 
PCV3
ChartChart
  72 
Pol3
ChartChart
  81  76  79  83  58  66  56 
RCV1
ChartChart
 
RotaC
ChartChart
 
YFV
ChartChart
  49  49  69  73  49  60 

Number of districts in the country 82  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 62
From 80 to 89% 29
From 50 to 79% 9
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 10 years; No From October 2015
IPV 14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10, 14 weeks; Yes From July 2016
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2010-2015  2011-2015  2011-2015  2011-2015  2011 - 2015  2011-2015  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 82  82  82  82  102  83  83 

System performance

Total Nº districts in country number 82  82  82    102  83  83 
Nº districts with DTP3 coverage >=80% number 75  61  81    14  53  47 
% of districts with DTP3 coverage >=80% From 0 to 100% 91  74  99    14  64  57 
Nº districts with measles (MCV1) coverage >=95% number 19   
% of districts with MCV1 coverage >=95% From 0 to 100% 11  23   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  No  No  No   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  No  No  No  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 63  10  83    35  53  32 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.